Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K)

被引:31
作者
Grubber, JM
Saunders, AM
Crane-Gatherum, AR
Scott, WK
Martin, ER
Haynes, CS
Conneally, PM
Small, GW
Roses, AD
Haines, JL
Pericak-Vance, MA
机构
[1] Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Durham, NC 27710 USA
[2] Glaxo Wellcome Inc, Res & Dev, GEnet Directorate, Res Triangle Pk, NC 27709 USA
[3] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90024 USA
[5] Vanderbilt Univ, Program Human Genet, Nashville, TN 37232 USA
关键词
butyrylcholinesterase gene; apolipoprotein E; Alzheimer disease; transmission disequilibrium test; association; linkage disequilibrium;
D O I
10.1016/S0304-3940(99)00426-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Butyrylcholinesterase (BCHE) is an enzyme expressed in most human tissues. Recently, an increased odds of carrying the K variant of BCHE (BCHE-K) was reported among Alzheimer disease (AD) cases as compared with controls. We tested our data set of 245 sporadic AD cases and 241 controls for an association between BCHE-K, APOE4, and AD using logistic regression and chi-square analyses. The sib transmission disequilibrium test (S-TDT) was also used to test for differences in BCHE-K allele frequencies between 163 discordant sib-pairs selected from multiplex AD families. No statistically significant differences were noted between BCHE-K case and control allele frequencies even after stratifying by APOE4 status. S-TDT analysis between the BCHE-K variant and AD was also not significant (P = 0.52). We conclude that BCHE-K is not a major genetic risk factor for AD in our study population. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 21 条
[1]  
[Anonymous], NEUROBIOL AGING
[2]   ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative [J].
Blacker, D ;
Haines, JL ;
Rodes, L ;
Terwedow, H ;
Go, RCP ;
Harrell, LE ;
Perry, RT ;
Bassett, SS ;
Chase, G ;
Meyers, D ;
Albert, MS ;
Tanzi, R .
NEUROLOGY, 1997, 48 (01) :139-147
[3]   Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease [J].
Brindle, N ;
Song, Y ;
Rogaeva, E ;
Premkumar, S ;
Levesque, G ;
Yu, G ;
Ikeda, M ;
Nishimura, M ;
Paterson, A ;
Sorbi, S ;
Duara, R ;
Farrer, L ;
St George-Hyslop, P .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :933-935
[4]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[5]   The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations [J].
Crawford, F ;
Fallin, D ;
Suo, Z ;
Abdullah, L ;
Gold, M ;
Gauntlett, A ;
Duara, R ;
Mullan, M .
NEUROSCIENCE LETTERS, 1998, 249 (2-3) :115-118
[6]   Genetics and the dementia patient [J].
Farrer, LA .
NEUROLOGIST, 1997, 3 (01) :13-30
[7]  
Goate A. M., 1991, NATURE, V33, P53
[8]   Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients [J].
Hiltunen, M ;
Mannermaa, A ;
Helisalmi, S ;
Koivisto, A ;
Lehtovirta, M ;
Ryynänen, M ;
Riekkinen, P ;
Soininen, H .
NEUROSCIENCE LETTERS, 1998, 250 (01) :69-71
[9]   Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease [J].
Lehmann, DJ ;
Johnston, C ;
Smith, AD .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1933-1936
[10]   CANDIDATE GENE FOR THE CHROMOSOME-1 FAMILIAL ALZHEIMERS-DISEASE LOCUS [J].
LEVYLAHAD, E ;
WASCO, W ;
POORKAJ, P ;
ROMANO, DM ;
OSHIMA, J ;
PETTINGELL, WH ;
YU, CE ;
JONDRO, PD ;
SCHMIDT, SD ;
WANG, K ;
CROWLEY, AC ;
FU, YH ;
GUENETTE, SY ;
GALAS, D ;
NEMENS, E ;
WIJSMAN, EM ;
BIRD, TD ;
SCHELLENBERG, GD ;
TANZI, RE .
SCIENCE, 1995, 269 (5226) :973-977